Key terms
About XTNT
Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoSTX, Certex Spinal Fixation System, Axle Interspinous Fusion System, and Calix. The company was founded in 2006 and is headquartered in Belgrade, MT.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest XTNT news
Apr 02
5:11am ET
Analysts Offer Insights on Healthcare Companies: Rocket Pharmaceuticals (RCKT), Liquidia Technologies (LQDA) and Xtant Medical Holdings (XTNT)
Apr 02
2:01am ET
Xtant Medical’s Earnings at Risk: The Unhedged Perils of Currency Fluctuations
Apr 01
8:36am ET
Xtant Medical Holdings (XTNT) Receives a Buy from Craig-Hallum
Apr 01
7:07am ET
Xtant Medical sees FY24 revenue $112M-$116M
Apr 01
7:07am ET
Xtant Medical reports Q4 EPS (3c) vs (2c) last year
Mar 28
9:10am ET
Analysts Are Bullish on These Healthcare Stocks: Trulieve Cannabis (TCNNF), Xtant Medical Holdings (XTNT)
Mar 08
8:50am ET
Analysts Offer Insights on Healthcare Companies: Joint (JYNT), Xtant Medical Holdings (XTNT) and Oncternal Therapeutics (ONCT)
Mar 07
5:22pm ET
Xtant Medical Revamps Finance Strategy with New Credit Facilities
Jan 07
5:50am ET
Analysts Offer Insights on Healthcare Companies: Xtant Medical Holdings (XTNT), Apollo Medical Holdings (AMEH) and Atricure (ATRC)
Jan 07
5:50am ET
BTIG Reaffirms Their Buy Rating on Xtant Medical Holdings (XTNT)
No recent press releases are available for XTNT
XTNT Financials
Key terms
Ad Feedback
XTNT Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
XTNT Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
